Polymorphisms causing glutathione transferase deficiencies (GSTM1) may result in elevated breast cancer risk from PAHs.[2] Other risk factors may include blood group, with type A individuals having a greater risk of certain types of cancer, although this can be masked by other genetic factors overriding the blood group phenotype.[3]